Colcrys for Acute Gout Asheville NC

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

Atlas Family Chiropractic
(828) 253-0700
190 Broadway Ave Ste 205
Asheville, NC

Data Provided by:
Merrimon Family Chiropractic
(828) 255-8333
338 Merrimon Ave
Asheville , NC

Data Provided by:
Animal Hospital South
(828) 277-0600
1306 Hendersonville Rd
Asheville, NC

Data Provided by:
Whittington Chiropractic
(828) 298-0011
801 Fairview Rd
Asheville, NC

Data Provided by:
Animal Hospital East
(828) 298-6585
1275 Tunnel Rd
Asheville, NC

Data Provided by:
Envision Eyecare
(828) 398-1537
180 Charlotte St
Asheville, NC

Data Provided by:
Lawson Chiropractic
(828) 274-8880
80 Peachtree Rd
Asheville, NC

Data Provided by:
Chiropractic Family Practice helping families
(828) 299-4555
16 Winterwind Dr
Asheville, NC

Data Provided by:
Haw Creek Animal Hospital
(828) 298-1678
1007 Tunnel Rd
Asheville, NC

Data Provided by:
Edgewood Chiropractic & Wellness
(828) 604-1185
959 Merrimon Ave # D suite 102
Asheville, NC

Data Provided by:
Data Provided by:

Colcrys for Acute Gout

Provided By:

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

In a news release, the agency said colchicine has been used as a remedy to treat acute gout flares "for many years," despite that it hadn't been FDA approved. The agency said it was in the midst of a program to bring other similarly unapproved products under its regulatory authority.

A dosing study required for approval led the agency to recommend a lower dosing regimen for Colcrys that had been commonly prescribed, the news release said. This was designed to prevent gastrointestinal problems.

The FDA said it was alerting healthcare professionals of the lower dosing schedule and also warning that the drug had the potential for severe interactions with other medications.

FMF, common in Mediterranean nations but less so in the United States, has symptoms including fever, arthritis, and inflammation of the lining of the lungs and abdomen. Colcrys is now the first drug that's been FDA-approved to treat FMF, the agency said.

The drug is produced by Philadelphia-based Mutual Pharmaceutical Company Inc.

More information

The FDA has more about this medication's approval.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com